Efinopegdutide
A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)
Merck · Phase 1 · Completed · Enrollment 48
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Part 1: Efinopegdutide | n/r | n/r | n/r | n/r | n/r |
| Part 1: Placebo | n/r | n/r | n/r | n/r | n/r |
| Part 2: Efinopegdutide | n/r | n/r | n/r | n/r | n/r |
| Part 2: Placebo | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.